Cardinal Health (NYSE:CAH) PT Raised to $130.00

Cardinal Health (NYSE:CAH) had its price target upped by equities research analysts at Robert W. Baird from $129.00 to $130.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of 36.00% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the stock. Evercore ISI boosted their target price on shares of Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a research note on Friday, May 3rd. Wells Fargo & Company reduced their target price on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a research note on Monday, April 29th. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 2nd. Finally, Argus reduced their price target on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. One analyst has rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.

Cardinal Health Stock Down 0.4 %

NYSE:CAH opened at $95.59 on Tuesday. Cardinal Health has a 12 month low of $85.11 and a 12 month high of $116.04. The firm has a market cap of $23.28 billion, a price-to-earnings ratio of 42.48, a P/E/G ratio of 1.07 and a beta of 0.61. The company’s 50 day moving average is $98.78 and its 200-day moving average is $104.19.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The business had revenue of $54.90 billion for the quarter, compared to analyst estimates of $56.05 billion. During the same quarter in the previous year, the firm posted $1.74 earnings per share. Cardinal Health’s revenue was up 8.7% compared to the same quarter last year. Research analysts predict that Cardinal Health will post 7.35 EPS for the current fiscal year.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds have recently made changes to their positions in the business. Aaron Wealth Advisors LLC grew its stake in shares of Cardinal Health by 1.2% during the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock worth $844,000 after acquiring an additional 97 shares in the last quarter. Schechter Investment Advisors LLC grew its stake in shares of Cardinal Health by 4.1% in the fourth quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock valued at $250,000 after buying an additional 98 shares in the last quarter. J. W. Coons Advisors LLC grew its stake in shares of Cardinal Health by 0.6% in the fourth quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company’s stock valued at $1,681,000 after buying an additional 100 shares in the last quarter. Edmonds Duncan Registered Investment Advisors LLC grew its stake in shares of Cardinal Health by 5.0% in the first quarter. Edmonds Duncan Registered Investment Advisors LLC now owns 2,090 shares of the company’s stock valued at $234,000 after buying an additional 100 shares in the last quarter. Finally, Checchi Capital Advisers LLC grew its stake in shares of Cardinal Health by 3.2% in the first quarter. Checchi Capital Advisers LLC now owns 3,758 shares of the company’s stock valued at $421,000 after buying an additional 115 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.